Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 98 member B (FAM98B) is a protein-coding gene whose protein product acts as a component of the tRNA-splicing ligase complex[1][9][12]. It is involved in positive regulation of protein arginine methylation, gene expression, and cell proliferation[2][9][12]. FAM98B can stimulate PRMT1-induced protein arginine dimethylation and interacts with various partners in RNA processing and modification complexes[1][2]. The protein is localized in both the cytoplasm and nucleoplasm and demonstrates RNA binding activity[2][12]. Overexpression or altered regulation of FAM98B has been implicated in certain malignancies, including colorectal cancer, where it appears to promote cell malignancy, and high expression can have prognostic impact in some cancers[1][4]. While FAM98B is functionally important in fundamental cellular processes, it is not a well-characterized direct drug target, nor is it classified as a receptor, enzyme, transporter, or transcription factor per conventional therapeutic targeting frameworks[1][2][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 98 member B (FAM98B).